Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01105663 · ClinicalTrials.gov registry record
Pharmacologic Impact on Sedation Assessments
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 175
- Enrollment target
NCT01105663 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 175 participants.
The verdict
NCT01105663 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
PISA is an ancillary study to the NIH funded clinical RESTORE Trial (U01 HL086622). This study will provide data that may allow for improved dosing recommendations in this critically ill population of children.
Interventions
- OTHER Pharmacokinetic Sampling and pharmacogenetic analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01105663
The ClinicalTrials.gov registry entry for NCT01105663 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacokinetic Sampling and pharmacogenetic analysis is the first listed.
NCT01105663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01105663 about?
NCT01105663 is a clinical study titled "Pharmacologic Impact on Sedation Assessments". PISA is an ancillary study to the NIH funded clinical RESTORE Trial (U01 HL086622). This study will provide data that may allow for improved dosing recommendations in this critically ill population of children.
What is the current status of trial NCT01105663?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2010-03. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01105663?
The interventions under investigation include: Pharmacokinetic Sampling and pharmacogenetic analysis (OTHER).
Who is sponsoring clinical trial NCT01105663?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.